Neuren Pharmaceuticals | NEU - Market Capitalization

Stock Price
11.48
Daily Change
0.08 0.70%
Monthly
-12.23%
Yearly
-6.36%
Q1 Forecast
11.51

Neuren Pharmaceuticals reported AUD1.49B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 502M 75M Mar/2025
Alaunos Therapeutics USD 5M 2M Sep/2025
Avita Medical AUD 105.47M 35.32M Dec/2025
Clinuvel Pharmaceuticals AUD 520.28M 83.45M Jun/2025
Dianthus Therapeutics USD 1.57B 967M Sep/2025
Genetic Signatures AUD 18.65M 38.14M Mar/2026
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
Medical Developments International AUD 38.41M 24.12M Mar/2026
Neuren Pharmaceuticals AUD 1.71B 645.78M Mar/2026
Organon & Co USD 1.86B 916.43M Dec/2025
Paradigm Biopharmaceuticals AUD 91.31M 27.46M Mar/2026
PYC Therapeutics AUD 7.72B 6.76B Mar/2026
Starpharma Holdings AUD 179.24M 28.68M Mar/2026
Tectonic Therapeutic USD 294M 77M Sep/2025
Telix Pharmaceuticals AUD 5.07B 5.81B Dec/2025
Viatris USD 14.34B 2.8B Dec/2025
Xeris Pharmaceuticals USD 1.32B 562M Sep/2025